01 March 2006
Trustworthy alteration and improvement in adjuvant treatment of colon cancer.
Ali Harlak, Atilla SoranMed Sci Monit 2006; 12(3): RA46-52 :: ID: 447119
Abstract
Colorectal cancer is the third most common cancer both in men and womenin the United States. Advances in adjuvant treatment of colon cancer have came to consist of a successionof small improvements by large-scale clinical trials. The National Surgical Adjuvant Breast and BowelProject (NSABP) colon trials reflect the exciting history of progress in adjuvant treatment of coloncancer. Since 1977, the NSABP has successfully designed and conducted seven large-scale prospective randomizedclinical trials for colon cancers that has altered and improved the standard of care for patients withthis disease. More than 5,000 physicians, nurses, and other medical professionals at nearly 200 medicalsites from across the United States, Canada, Puerto Rico, Australia and New Zealand assist the NSABPin its mission to eliminate colorectal and breast cancers. These medical sites include several universityhospitals and many other local medical centers that treat patients from a variety of social, and economicbackgrounds contributed to the trials. The NSABP clinical trials are distinctive because of the largenumber of patients and elimination of social, cultural and economic influences. The ongoing trials ofthe NSABP should continue to provide information used to determine principals of neoadjuvant treatmentfor colon cancer. In this article we review seven prospective randomized clinical trials with their publishedresults and discuss the combined analysis of the first four trials.
Keywords: Clinical Trials as Topic, Chemotherapy, Adjuvant - statistics & numerical data, Colonic Neoplasms - therapy, Combined Modality Therapy, Disease-Free Survival, Follow-Up Studies, Neoplasm Staging, Randomized Controlled Trials as Topic, Survival Analysis, Time Factors
603 0
Editorial
01 June 2023 : Editorial
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic PreparednessDOI: 10.12659/MSM.941209
Med Sci Monit 2023; 29:e941209
In Press
07 Jun 2023 : Review article
Ultrasound-Guided Brachial Plexus Block by Costoclavicular Space Approach: A Narrative ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939920
05 Jun 2023 : Clinical Research
Comparison of Texture and Color Enhancement Imaging with White Light Imaging in 52 Patients with Short-Segm...Med Sci Monit In Press; DOI: 10.12659/MSM.940249
05 Jun 2023 : Laboratory Research
Comparison of Composite Resin (Duo-Shade) Shade Guide with Vita Ceramic Shades Before and After Chemical an...Med Sci Monit In Press; DOI: 10.12659/MSM.940949
02 Jun 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952